The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection
Official Title: Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection
Study ID: NCT04363632
Brief Summary: National multicentre epidemiological study to describe retrospectively and prospectively the clinical outcomes of patients with a suspected coronavirus infection (either confirmed or not) while receiving a medical treatment for the underlying cancer
Detailed Description:
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Institut Bergonié, Bordeaux, , France
Centre François Baclesse, Caen, , France
Centre Hospitalier Métropole Savoie, Chambéry, , France
Centre Jean Perrin, Clermont-Ferrand, , France
Centre Georges François Leclerc, Dijon, , France
Centre Oscar Lambret, Lille, , France
Centre Leon Berard, Lyon, , France
CH Annecy-Genevois, Metz-Tessy, , France
Institut de Cancérologie de Montpellier, Montpellier, , France
Groupement Hospitalier Porte de Provence, Montélimar, , France
Centre Antoine Lacassagne, Nice, , France
Centre Hospitalier Lyon-Sud, Pierre-Bénite, , France
Institut Jean Godinot, Reims, , France
Centre Henri Becquerel, Rouen, , France
Institut de Cancérologie de l'Ouest, Saint-Herblain, , France
Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg, , France
Institut Universitaire du Cancer de Toulouse - IUCT Oncopole, Toulouse, , France
CH Valence, Valence, , France